Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife
Closed portfolio snapshot
According to ClinicalTrials.gov-derived indexes, Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife sits in the upper half of US sponsors by registered trial count (#4,885 of 15,742 sponsors by registered trial count).
Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife: 2 sponsored US clinical trials, none currently recruiting.
Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife sponsors 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. The most-studied condition in this pipeline is Class IV Angina, with 1 trials.
Mid-pack sponsor footprint
Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife is in the upper half of sponsors by trial count (#4,885 of 15,742 sponsors by registered trial count). Use the pipeline list and therapeutic areas to see what drives that mid-pack volume.
Indexed trials (enrollment closed)
2 total, page 1 of 1
Therapeutic Areas
How the Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife archive is shaped
2 indexed studies, none listed as recruiting (0% open); 1 completed (50%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Class IV Angina (1 trial), 0 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife: archived-pipeline peers nationwide
Peers matched on 2 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 2 archived trials
- 1200 Pharma · 2 trials · 50% recruiting
- 1ST Biotherapeutics · 2 trials · 50% recruiting
- 3 Waves Wellness · 2 trials · 0% recruiting
- 3EO Health · 2 trials · 0% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife page
2 registered trials is a research-attention snapshot, not an endorsement of Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife or any single study.
- None of Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Class IV Angina is the condition Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Class IV Angina trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Cardiogenesis Corporation, a wholly-owned subsidiary of CryoLife pipeline card: 2 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.